trending Market Intelligence /marketintelligence/en/news-insights/trending/iq94afj0dpt1tst6dzl1la2 content esgSubNav
In This List

Addex raises CHF40M via capital offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Addex raises CHF40M via capital offering

Geneva-based Addex Therapeutics Ltd. completed a CHF40 million capital offering.

The company issued 13,037,577 new shares at CHF3.13 apiece.

Addex intends to use the proceeds to develop its portfolio of drug candidates, including registration studies for lead program dipraglurant, a treatment for Parkinson's disease.